Cargando…
Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides
Immunoassays are routinely used as research tools to measure intracellular cAMP and cGMP concentrations. Ideally, this application requires antibodies with high sensitivity and specificity. The present work evaluates the cross-reactivity of commercially available cyclic nucleotide analogs with two n...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145891/ https://www.ncbi.nlm.nih.gov/pubmed/21713381 http://dx.doi.org/10.1007/s00210-011-0662-6 |
_version_ | 1782209140350779392 |
---|---|
author | Werner, Katharina Schwede, Frank Genieser, Hans-Gottfried Geiger, Jörg Butt, Elke |
author_facet | Werner, Katharina Schwede, Frank Genieser, Hans-Gottfried Geiger, Jörg Butt, Elke |
author_sort | Werner, Katharina |
collection | PubMed |
description | Immunoassays are routinely used as research tools to measure intracellular cAMP and cGMP concentrations. Ideally, this application requires antibodies with high sensitivity and specificity. The present work evaluates the cross-reactivity of commercially available cyclic nucleotide analogs with two non-radioactive and one radioactive cAMP and cGMP immunoassay. Most of the tested cyclic nucleotide analogs showed low degree competition with the antibodies; however, with Rp-cAMPS, 8-Br-cGMP and 8-pCPT-cGMP, a strong cross-reactivity with the corresponding cAMP and cGMP, respectively, immunoassays was observed. The determined EIA-binding constants enabled the measurement of the intracellular cyclic nucleotide concentrations and revealed a time- and lipophilicity-dependent cell membrane permeability of the compounds in the range of 10–30% of the extracellular applied concentration, thus allowing a more accurate prediction of the intracellular analog levels in a given experiment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00210-011-0662-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3145891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-31458912011-09-21 Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides Werner, Katharina Schwede, Frank Genieser, Hans-Gottfried Geiger, Jörg Butt, Elke Naunyn Schmiedebergs Arch Pharmacol Original Article Immunoassays are routinely used as research tools to measure intracellular cAMP and cGMP concentrations. Ideally, this application requires antibodies with high sensitivity and specificity. The present work evaluates the cross-reactivity of commercially available cyclic nucleotide analogs with two non-radioactive and one radioactive cAMP and cGMP immunoassay. Most of the tested cyclic nucleotide analogs showed low degree competition with the antibodies; however, with Rp-cAMPS, 8-Br-cGMP and 8-pCPT-cGMP, a strong cross-reactivity with the corresponding cAMP and cGMP, respectively, immunoassays was observed. The determined EIA-binding constants enabled the measurement of the intracellular cyclic nucleotide concentrations and revealed a time- and lipophilicity-dependent cell membrane permeability of the compounds in the range of 10–30% of the extracellular applied concentration, thus allowing a more accurate prediction of the intracellular analog levels in a given experiment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00210-011-0662-6) contains supplementary material, which is available to authorized users. Springer-Verlag 2011-06-29 2011 /pmc/articles/PMC3145891/ /pubmed/21713381 http://dx.doi.org/10.1007/s00210-011-0662-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Werner, Katharina Schwede, Frank Genieser, Hans-Gottfried Geiger, Jörg Butt, Elke Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title | Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title_full | Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title_fullStr | Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title_full_unstemmed | Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title_short | Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
title_sort | quantification of camp and cgmp analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145891/ https://www.ncbi.nlm.nih.gov/pubmed/21713381 http://dx.doi.org/10.1007/s00210-011-0662-6 |
work_keys_str_mv | AT wernerkatharina quantificationofcampandcgmpanalogsinintactcellspitfallsinenzymeimmunoassaysforcyclicnucleotides AT schwedefrank quantificationofcampandcgmpanalogsinintactcellspitfallsinenzymeimmunoassaysforcyclicnucleotides AT genieserhansgottfried quantificationofcampandcgmpanalogsinintactcellspitfallsinenzymeimmunoassaysforcyclicnucleotides AT geigerjorg quantificationofcampandcgmpanalogsinintactcellspitfallsinenzymeimmunoassaysforcyclicnucleotides AT buttelke quantificationofcampandcgmpanalogsinintactcellspitfallsinenzymeimmunoassaysforcyclicnucleotides |